Trial intelligence / Profile preview

Cefbuperazone vs cefmetazole for acute respiratory and urinary tract infections

CTR20150130Phase 3Completed

Sponsor
Hainan General Sanyo Pharmaceutical
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cefbuperazone in bacterial airway infections, urinary tract infection (UTI), sponsored by Hainan General Sanyo Pharmaceutical. Started Apr 2015; status: completed.

02

Drugs

cefbuperazone
03

Conditions

bacterial airway infectionsurinary tract infection (UTI)

Beyond the preview

Go deeper on CTR20150130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call